Showing results (91-100 of 1,008) with videos related to
Sort By:
Pageof 101
Diabetes, Obesity & Metabolism|March 30, 2021
Sex differences in risk factors for cognitive decline and dementia, including death as a competing risk, in individuals with diabetes: Results from the ADVANCE trialJessica Gong, Katie Harris, Maree Hackett, et al.Cerebral Circulation - Cognition and Behavior|January 6, 2025
Effect of randomised blood pressure lowering treatment and intensive glucose control on dementia and cognitive decline according to baseline cognitive function and other subpopulations of individuals with type 2 diabetes: Results from the ADVANCE trialKatie Harris, Jessica Gong, Stephen MacMahon, et al.Nutrition & Diabetes|January 19, 2018
Associations between body mass index and the risk of renal events in patients with type 2 diabetesKamel Mohammedi, John Chalmers, William Herrington, et al.Journal of Hypertension|April 22, 2021
Combination blood pressure lowering in the presence or absence of background statin and aspirin therapy: a combined analysis of PROGRESS and ADVANCE TrialsNelson Wang, Katie Harris, John Chalmers, et al.Progress in Cardiovascular Diseases|July 13, 2010
The Framingham Study, diabetes mellitus and cardiovascular disease: turning back the clockAndre Pascal Kengne, Fiona Turnbull, Stephen MacMahonCirculation Research|March 14, 2015
The epidemiology of blood pressure and its worldwide managementKazem Rahimi, Connor A Emdin, Stephen MacMahonCirculation|June 15, 2016
Prevention and Control of Cardiovascular Disease in the Rapidly Changing Economy of ChinaYangfeng Wu, Emelia J Benjamin, Stephen MacMahonEuropean Heart Journal. Quality of Care & Clinical Outcomes|February 24, 2018
Replacing the hypertension control paradigm with a strategy of cardiovascular risk reductionJohan Sundström, Bruce NealDiabetes Care|October 6, 2011
Does glycemic control offer similar benefits among patients with diabetes in different regions of the world? Results from the ADVANCE trialMark Woodward, Anushka Patel, Sophia Zoungas, et al.The Cochrane Database of Systematic Reviews|April 2, 2013
WITHDRAWN: Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplastyMarlene Fransen, Bruce NealPageof 101